IP Library Granted Patent US 11,891,341
Granted Patent B2
US 11,891,341 · App. 16/888,724 · Granted Feb 6, 2024

Preceramic 3D-printing monomer and polymer formulations

Inventors: Zak C. Eckel (Thousand Oaks, CA); Andrew P. Nowak (Los Angeles, CA); Ashley M. Dustin (Los Angeles, CA); April R. Rodriguez (Santa Monica, CA); Phuong Bui (Thousand Oaks, CA); Tobias A. Schaedler (Oak Park, CA)
Assignee: HRL Laboratories, LLC
C04B35/571B28B1/001B33Y70/00B33Y80/00C08G77/50C04B2235/5252C04B2235/665
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,891,341
App. No.
16/888,724
Granted
Feb 6, 2024
Kind
B2
Abstract

This disclosure provides resin formulations which may be used for 3D printing and thermally treating to produce a ceramic material. The disclosure provides direct, free-form 3D printing of a preceramic polymer, followed by converting the preceramic polymer to a 3D-printed ceramic composite with potentially complex 3D shapes. A wide variety of chemical compositions is disclosed, and several experimental examples are included to demonstrate reduction to practice. For example, preceramic resin formulations may contain a carbosilane in which there is at least one functional group selected from vinyl, allyl, ethynyl, unsubstituted or substituted alkyl, ester group, amine, hydroxyl, vinyl ether, vinyl ester, glycidyl, glycidyl ether, vinyl glycidyl ether, vinyl amide, vinyl triazine, vinyl isocyanurate, acrylate, methacrylate, alkacrylate, alkyl alkacrylate, phenyl, halide, thiol, cyano, cyanate, or thiocyanate. The resin formulations may contain a solid-phase filler, to provide high thermal stability and mechanical strength (e.g., fracture toughness) in the final ceramic material.

Claims (18)

1. A preceramic resin formulation for 3D-printing and free-radical or cationic polymerization, said preceramic resin formulation comprising:

(a) a functionalized carbosilane having the chemical structure:

wherein:

R 1 is selected from the group consisting of an allyl group, an ethynyl group a vinyl ether group, a glycidyl group, a glycidyl ether group, a vinyl glycidyl ether group, a vinyl amide group, a vinyl triazine group, a vinyl isocyanurate group, a cyano group, a cyanate group, a thiocyanate group, and combinations thereof;

R 2 is selected from the group consisting of an allyl group, an ethynyl group a vinyl ether group, a glycidyl group, a glycidyl ether group, a vinyl glycidyl ether group, a vinyl amide group, a vinyl triazine group, a vinyl isocyanurate group, a cyano group, a cyanate group, and combinations thereof; and

n=2 to 100;

(b) a photoinitiator;

(c) a free-radical inhibitor; and

(d) a 3D-printing resolution agent, wherein said 3D-printing resolution agent is selected for its capability to improve 3D-print quality and resolution by containing curing to a desired region of light exposure laterally and/or vertically in a pre-cured print bath via absorbing said light at a first wavelength and converting energy produced therefrom into thermal energy or radiation at a higher wavelength.

2. The preceramic resin formulation of claim 1 , wherein at least one of R 1 or R 2 is an allyl group.

3. The preceramic resin formulation of claim 1 , wherein said preceramic resin formulation contains at least two distinct functionalized carbosilanes that are each in accordance with said chemical structure, wherein R 1 , R 2 , and n are independently selected for said distinct functionalized carbosilanes.

4. The preceramic resin formulation of claim 1 , wherein said photoinitiator is present in a concentration from about 0.001 wt % to about 10 wt % in said preceramic monomer formulation.

5. The preceramic resin formulation of claim 1 , wherein said free-radical inhibitor is present in a concentration from about 0.001 wt % to about 10 wt % in said preceramic monomer formulation.

6. The preceramic resin formulation of claim 1 , wherein said 3D-printing resolution agent is present in a concentration from about 0.001 wt % to about 10 wt % in said preceramic resin formulation.

7. The preceramic resin formulation of claim 1 , wherein said preceramic monomer formulation further comprises a thermal free-radical initiator.

8. The preceramic resin formulation of claim 1 , wherein said preceramic resin formulation further contains a crosslinking agent.

9. The preceramic resin formulation of claim 1 , wherein said preceramic monomer formulation further comprises from about 0.1 vol % to about 70 vol % of solid-phase fillers.

10. The preceramic resin formulation of claim 1 , wherein said 3D-printing resolution agent is selected from the group consisting of 2-hydroxyphenyl-benzophenones, 2-hydroxyphenyl-s-triazines, 2,2′-(2,5-thiophenediyl)bis(5-tert-butylbenzoxazole), 2,2′-(1,2-ethenediyl)bis(4,1-phenylene)bisbenzoxazole, and combinations thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 30, 2020
From: ECKEL, ZAK C.; NOWAK, ANDREW P.; DUSTIN, ASHLEY M.; RODRIGUEZ, APRIL R.; BUI, PHUONG; SCHAEDLER, TOBIAS A.
To: HRL LABORATORIES, LLC
Reel/Frame 052795/0190 →
Continuity (6)
Continuation In Part 15822199 · Nov 26, 2017
Provisional Application 62556388 · Sep 9, 2017
Provisional Application 62428203 · Nov 30, 2016
Provisional Application 62428213 · Nov 30, 2016
Provisional Application 62428207 · Nov 30, 2016
Related Publication 20200290931A1 · Sep 17, 2020